Theratechnologies présentera des données à long terme sur l’efficacité, l’innocuité et la pharmacocinétique de l’utilisation du TH1902 (sudocétaxel zendusortide) dans les tumeurs solides lors du Congrès 2024 de l’ASCO
May 02, 2024 07:30 ET
|
Theratechnologies
Dévoilement de données à long terme des parties 1 et 2 de l’essai clinique de phase I portant sur le sudocétaxel zendusortide dans les tumeurs solidesLa partie 3 de la phase I de l’essai sur le cancer...
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
May 02, 2024 07:30 ET
|
Theratechnologies
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing MONTREAL,...
AppTech Payments Corp. to Present at Sidoti Virtual Investor Conference May 8-9
May 02, 2024 07:30 ET
|
AppTech Corp.
CARLSBAD, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, announced Luke D’Angelo, Chairman & CEO,...
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
May 02, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
May 02, 2024 07:15 ET
|
Ocugen
MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024 07:15 ET
|
Alvotech
REYKJAVIK, Iceland, May 02, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
NanoXplore organise une webdiffusion pour discuter des résultats du troisième trimestre le 15 mai 2024
May 02, 2024 07:15 ET
|
NanoXplore Inc.
MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. (" NanoXplore " ou la " Société ") (TSX : GRA et OTCQX : NNXPF) a le plaisir d'organiser une webdiffusion pour discuter des résultats...
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 15th, 2024
May 02, 2024 07:15 ET
|
NanoXplore Inc.
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its third quarter ended March 31, 2024,...
Gilat to Participate in the 19th Annual Needham Technology, Media & Consumer Conference on May 15, 2024
May 02, 2024 07:03 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today...
Sotera Health Reports First-Quarter 2024 Results
May 02, 2024 07:00 ET
|
Sotera Health Services, LLC
Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in...